SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-277660
Filing Date
2019-10-29
Accepted
2019-10-30 08:09:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d813887dsc13g.htm SC 13G 42064
  Complete submission text file 0001193125-19-277660.txt   43560
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 191177890
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 GRESHAM STREET LONDON X0 EC2V 7NQ
Business Address 65 GRESHAM STREET LONDON X0 EC2V 7NQ 44 (0)20 7954 9710
Link Fund Solutions Ltd (Filed by) CIK: 0001792424 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G